RADX

About Radiopharm Theranostics Limited American Depositary Shares (RADX) Stock

Radiopharm Theranostics Limited American Depositary Shares (RADX) closed the 2026-09-16 session at $1.67, up 9.87% versus the previous close (+0.15). The stock opened at $1.56 and traded between $1.55 and $1.80 during that session. Session trading volume was 188K shares. The volume-weighted average price (VWAP) is $1.67.

Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.

Radiopharm Theranostics Limited American Depositary Shares has a market capitalization of $24.1 million. RADX is listed on the XNAS exchange. The company employs approximately 14 people. The recorded listing date is 2024-11-27.

On this page you can find market RADX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.